Biodegradable and programmable, organic thin films show promise

If it’s biodegradable, then odds are it can be used for drug delivery. Why? Carnegie Mellon University’s Christopher Bettinger, an assistant professor of materials science and biomedical engineering, says it best.

“We are working with biodegradable polymers because they are non-toxic and capable of a controlled rate of degradation,” he says in a release announcing his work. "In the case of drug delivery, we find that the polymer slowly degrades into smaller fragments, releasing a natural product in a controlled environment."

What Bettinger is doing that seems counterintuitive. He is investigating use of organic thin film transistor technology to integrate electronic devices into a very wet environment like the human body.

"We found that by combining small-molecular semiconductors and biodegradable polymers it allows for potential electronic functionality in biodegradable medical implants that has previously been unattainable," Bettinger says in the release.

- see the CMU release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.